Behavioral Therapy Development for Methamphetamine Abusers

Withdrawn before enrolling · Phase 2

Conditions studied: The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings

In brief

The purpose of this study is...to assess whether placing a substance abuse intervention for HIV+ methamphetamine users within an HIV medical care setting improves rates of follow-up on referral to treatment by primary care physicians; reduces drug use and sexual risk behaviors more than treatment-as-usual; and increases rates of adherence to HIV medication regimens.

Key facts

Study ID

NCT00249678

Run by

University of California, Los Angeles

People needed

0

Starts

2004-09-01

Expected to finish

2007-05-01

Last updated by the study team

2020-02-17

Who can join

Age: 18 and older, up to 65. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• HIV-seropositive, GBM receiving medical treatment for HIV for at least 30 days prior to signing informed consent at the UCLA CARE clinic, aged 18-65
• Willing to give informed consent and comply with study procedures;
• Willing to provide consent to contact treating physicians and pharmacies to assess adherence to HIV medications;
• Diagnosed with current methamphetamine abuse as determined by MINI; and
• Interested in seeking treatment for their methamphetamine abuse and in participating in this research project.

You may not qualify if…

• Unwilling to give, or withdrawal of, informed consent;
• Inability to understand nature of study;
• A psychiatric condition that, in the principal investigator's judgment, warrants additional intervention to ensure participant safety (e.g., meets DSM-IV-TR criteria for current bipolar disorder or a psychotic disorder);
• Current suicidal ideation or suicide attempt within the past 3 months; and
• Concurrent dependence on opiates, alcohol, or benzodiazepines as determined by MINI.
• Total lack of any type of healthcare coverage. These potential participants will be given low-fee treatment referrals.

Where it is running

• UCLA Medical Center — Los Angeles, California, United States
• UCLA, Integrated Substance Abuse Programs — Los Angeles, California, United States
• UCLA CARE Clinic — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.